These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9255232)

  • 1. Effects of growth hormone treatment in children with cystic fibrosis: the National Cooperative Growth Study experience.
    Hardin DS; Sy JP
    J Pediatr; 1997 Jul; 131(1 Pt 2):S65-9. PubMed ID: 9255232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anabolic effects of growth hormone treatment in young children with cystic fibrosis.
    Alemzadeh R; Upchurch L; McCarthy V
    J Am Coll Nutr; 1998 Oct; 17(5):419-24. PubMed ID: 9791837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GH improves growth and clinical status in children with cystic fibrosis -- a review of published studies.
    Hardin DS
    Eur J Endocrinol; 2004 Aug; 151 Suppl 1():S81-5. PubMed ID: 15339250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial.
    Hardin DS; Adams-Huet B; Brown D; Chatfield B; Dyson M; Ferkol T; Howenstine M; Prestidge C; Royce F; Rice J; Seilheimer DK; Steelman J; Shepherds R
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4925-9. PubMed ID: 17018651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition.
    Hardin DS; Rice J; Ahn C; Ferkol T; Howenstine M; Spears S; Prestidge C; Seilheimer DK; Shepherd R
    J Pediatr; 2005 Mar; 146(3):324-8. PubMed ID: 15756212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recombinant human growth hormone on height and skeletal maturation in growth hormone-deficient children with and without severe pretreatment bone age delay.
    Frindik JP; Kemp SF; Sy JP
    Horm Res; 1999; 51(1):15-9. PubMed ID: 10095164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I levels predict weight, height and protein catabolism in children and adolescents with cystic fibrosis.
    Switzer M; Rice J; Rice M; Hardin DS
    J Pediatr Endocrinol Metab; 2009 May; 22(5):417-24. PubMed ID: 19618660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A; Simon D; Czernichow P
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition.
    Lai HC; Kosorok MR; Sondel SA; Chen ST; FitzSimmons SC; Green CG; Shen G; Walker S; Farrell PM
    J Pediatr; 1998 Mar; 132(3 Pt 1):478-85. PubMed ID: 9544905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 4-Year, Open-Label, Multicenter, Randomized Trial of Genotropin® Growth Hormone in Patients with Idiopathic Short Stature: Analysis of 4-Year Data Comparing Efficacy, Efficiency, and Safety between an Individualized, Target-Driven Regimen and Standard Dosing.
    Counts DR; Silverman LA; Rajicic N; Geffner ME; Newfield RS; Thornton P; Carakushansky M; Escobar O; Rapaport R; Levitsky L; Rotenstein D; Hey-Hadavi J; Wajnrajch MP
    Horm Res Paediatr; 2015; 84(2):79-87. PubMed ID: 25966824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa.
    van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koèelega AC
    J Clin Endocrinol Metab; 2016 May; 101(5):2005-12. PubMed ID: 26964733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
    Darendeliler F; Lindberg A; Wilton P
    Horm Res Paediatr; 2011; 76 Suppl 1():42-6. PubMed ID: 21778748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response to growth hormone treatment in prepubertal children with growth hormone deficiency in Japan: Comparing three consecutive years of treatment data of The Foundation for Growth Science in Japan between the 1990s and 2000s.
    Isojima T; Hasegawa T; Yokoya S; Tanaka T
    Endocr J; 2017 Sep; 64(9):851-858. PubMed ID: 28679975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
    Wit JM; Rekers-Mombarg LT; Cutler GB; Crowe B; Beck TJ; Roberts K; Gill A; Chaussain JL; Frisch H; Yturriaga R; Attanasio AF
    J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.